Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
TBK1-associated frontotemporal dementia (FTD) is inherited in an autosomal dominant manner due to heterozygous loss-of-function variants in the TANK-binding kinase 1 (TBK1) gene, leading to haploinsufficiency of a key regulator of autophagy and innate immunity.
In a Belgian cohort of 481 FTD patients, 5 unrelated probands carrying TBK1 LoF mutations were identified, representing 1.1% of cases, with segregation of the recurrent c.1928_1930del (p.Glu643del) variant in 6 affected relatives in a large family (PMID:26581300). The same c.1928_1930del (p.Glu643del) mutation has been observed in multiple additional FTD-ALS families, reinforcing its pathogenicity.
Exonic resequencing in a European Early-Onset Dementia Consortium cohort of 2,538 FTD, ALS, and FTD-ALS patients revealed TBK1 LoF variants in 0.4% of isolated FTD cases, 1.3% of ALS cases, and 3.6% of combined FTD-ALS cases, with functional assays confirming transcript loss via nonsense-mediated decay (PMID:28008748).
Functional studies demonstrate that TBK1 haploinsufficiency alters K63-linked ubiquitination profiles in brain tissue and patient fibroblasts, reduces phosphorylation of autophagy and interferon regulatory substrates, and impairs TBK1–IRF3 complex formation, consistent with a loss-of-function mechanism in FTD models (PMID:34800171; PMID:36113750).
Clinically, TBK1-related FTD manifests as a right temporal variant with progressive behavioral change, apathy, and memory impairment, often with TDP-43 type A pathology at autopsy. The overlap with ALS and other neurodegenerative syndromes underscores the importance of including TBK1 in genetic panels for FTD and FTD-ALS.
Key Take-home: TBK1 LoF variants are a definitive cause of autosomal dominant FTD; genetic testing for TBK1 should be considered in FTD patients, especially those with temporal-predominant atrophy or combined motor neuron features.
Gene–Disease AssociationDefinitive5 FTD probands and 6 segregating relatives in Belgian cohort (PMID:26581300); replication across European cohorts with functional LoF confirmation (PMID:28008748) Genetic EvidenceStrongHeterozygous TBK1 LoF variants identified in 5 unrelated FTD probands (PMID:26581300) and segregating in 6 relatives, meeting ClinGen genetic evidence cap Functional EvidenceStrongIn vitro and in vivo data show TBK1 haploinsufficiency disrupts autophagy and interferon signaling, with altered K63-ubiquitination and impaired IRF3 phosphorylation (PMID:34800171; PMID:36113750) |